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do the Editor: To date, the only common genetic variant to
onsistently associate with risk of coronary artery disease (CAD) or
yocardial infarction (MI) is the 9p21.3 variant (1,2). Several
ecent reports identified a SNP (rs20455) that alters an amino acid
n the KIF6 protein (Trp719Arg) and associates with acute
oronary events and the response to statin therapy (3–5). However,
ecent genome-wide association studies for CAD (1) or MI (71%
I in the WTCCC [Wellcome Trust Case Control Consortium]
tudy and 100% MI in the GMIF [German Myocardial Infarction
n Families] study) (2) did not report this association. Since the
s20455 SNP is present on the Affymetrix (Santa Clara, Califor-
ia) 500K and the 6.0 single nucleotide polymorphism (SNP)
icroarrays, we used data from the ongoing OHGS (Ottawa
eart Genomics Study) and the WTCCC study to test whether
s20455 associates with CAD.
Written informed consent was obtained from all study partici-
ants according to a protocol approved by the Research Ethics
oard of the University of Ottawa Heart Institute. A sample size
f 1,500 cases and 1,500 controls was estimated to detect alleles
ssociated with CAD in an additive model based on an odds ratio
f 1.3, a minor allele frequency 10%, with a level of signifi-
ance of 0.001 and a power of 90%. Cases with onset before the
ge of 55 years in males and 65 years in females were eligible. Cases
ere recruited through the coronary catheterization laboratory and
he lipid clinic of the University of Ottawa Heart Institute.
ubjects with diabetes mellitus and overt hyperlipidemia were
xcluded. Asymptomatic elderly persons without cardiovascular
isease history were selected as controls (65 years of age for
ales, 70 years of age for females) and recruited by an advertis-
ng campaign in the Ottawa community.
The rs20455 SNP was genotyped for 1,606 cases and 1,472
ontrols using the Affymetrix 500K or 6.0 SNP arrays. In a subset
f samples, genomic deoxyribonucleic acid was amplified by
olymerase chain reaction (PCR [primers: rs20455 forward 5=-
CA CTG TGA AAC TCC TTC TGG-3= and rs20455 reverse
o Association of Kif6 (rs20455) With CAD or MI in the Ottawa Heart Geno
Table 1 No Association of Kif6 (rs20455) With CAD or MI in the Ottawa
n CC CT TT M
CAD cases 1,540 183 695 662 0.3
Controls 1,455 205 616 634 0.3
CAD cases†
MI 706 79 320 307 0.3
Non-MI 756 97 333 326 0.3
Adjusted for age (cases 49  7 years, controls 75  5 years), sex (male cases 78%, male contro
2cases 72%, controls 47%), and body mass index (kg/m [cases 28.6  4.9, controls 26.0  4.0]). †Myo
CC  homozygous for the minor allele; CT  heterozygotes; MAF  minor allele frequency; TT  homo=-GCC ACTGTC TTG AGT ATC TACG-3=]) and genotyped
y high-resolution melting curve analysis according to the Roche
ightCycler 480 protocol. Population stratification was ascertained
sing the software Eigenstrat (Reich Lab, Harvard University), and
4 case and 17 control outliers were identified and removed. The
ochran-Armitage trend and dominant tests were used to evaluate
he association of rs20455 with CAD or MI using a threshold of
 0.001.
The 9p21.3 SNP rs1333049 showed a very strong association
ith CAD in our cohort (p  3.55  1013), serving as a positive
ontrol to detect a CAD risk variant. In contrast, no association
as detected for the rs20455 SNP with CAD, nor did rs20455
ssociate with MI among CAD cases (Table 1). We also geno-
yped 957 cases and 1,004 controls by PCR using the Lightcycler
Roche Applied Science, Laval, Quebec, Canada) protocol and
ound no association between rs20455 and CAD or MI. Of the
,518 case and control samples genotyped both by microarrays and
y PCR, a 98% concordance of the genotypes was observed, and
he difference did not account for the lack of association.
Our data do not support the hypothesis that Caucasian carriers
f the 719Arg allele of KIF6 have increased risk of CAD or MI in
he OHGS. Moreover, data from the WTCCC also showed no
ssociation of rs20455 with CAD (trend p  0.897). Because 71%
f cases in the WTCCC had an MI, it is also doubtful whether
s20455 SNP associates with MI in this cohort.
In the Women’s Health Study, the KIF6 variant was associated
ith coronary heart disease broadly defined as revascularization,
I, and cardiovascular death (4). If we perform the analysis
xcluding MI, the KIF6 variant shows no association with revas-
ularization or cardiovascular death. Thus, the association with the
omposite end point is apparently driven by MI. In a second report
rom the CARE (Cholesterol and Recurrent Events) trial and the
OSCOPS (West of Scotland Coronary Prevention Study)
ohorts, an association of the KIF6 variant with coronary heart
isease was observed. However, all cases were MI or cardiovascular
tudy
rt Genomics Study
p Value
Unadjusted
Trend
Adjusted
Trend*
Unadjusted
Dominant
Adjusted
Dominant*
0.523 0.248 0.768 0.461
0.588 0.494 0.916 0.830
, statin use (cases 89%, controls 24%), hypertension (cases 47%, controls 36%), smoking historymics S
Hea
AF
44
53
39
49
ls 52%)
cardial infarction (MI) data available on 1,462 coronary artery disease (CAD) cases.
zygous for the major allele.
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April 21, 2009:1471–2eath, supporting the idea that the KIF6 variant associates with
I rather than with CAD (3).
The OHGS is a cross-sectional case-control study designed to
dentify genes that predispose to angiographically defined CAD,
ot MI. A potential association between KIF6 and MI may be
onfounded by a higher CAD disease burden in our population.
enes that predispose specifically to MI rather than CAD would
ost readily be identified in MI patients with minimal CAD
urden.
Our study was not designed to test whether KIF6 is associated
ith a beneficial response to statin therapy, as reported (5).
lthough including statin use as a covariate did not make KIF6
ssociate with CAD or MI, it is possible that MI is under-
epresented among KIF6 carriers who are on a regimen of statin
herapy.
The 719Arg variant of KIF6 did not associate with risk of CAD
n either the OHGS or the WTCCC. Whether the KIF6 variant
s associated with MI or improves the benefit from statin therapy
waits confirmation in other studies.
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